These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 26371145)

  • 21. Lobular carcinoma in situ.
    Afonso N; Bouwman D
    Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
    Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.
    Wong SM; Stout NK; Punglia RS; Prakash I; Sagara Y; Golshan M
    Cancer; 2017 Jul; 123(14):2609-2617. PubMed ID: 28221673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS; Kestin LL; Vicini FA
    Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE
    J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lobular carcinoma in situ and invasive cancer: the contralateral breast controversy.
    Carolin KA; Tekyi-Mensah S; Pass HA
    Breast J; 2002; 8(5):263-8. PubMed ID: 12199752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
    Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
    Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS).
    McEvoy MP; Coopey SB; Mazzola E; Buckley J; Belli A; Polubriaginof F; Merrill AL; Tang R; Garber JE; Smith BL; Gadd MA; Specht MC; Guidi AJ; Roche CA; Hughes KS
    Ann Surg Oncol; 2015 Oct; 22(10):3346-9. PubMed ID: 26242364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobular Carcinoma
    Vora H; Kim S; Amersi F; Giuliano A; Chung A
    Am Surg; 2017 Oct; 83(10):1040-1044. PubMed ID: 29391091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
    Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status.
    Mao K; Yang Y; Wu W; Liang S; Deng H; Liu J
    PLoS One; 2017; 12(5):e0176417. PubMed ID: 28467490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience.
    Hoffman DI; Zhang PJ; Tchou J
    Surg Oncol; 2019 Mar; 28():190-194. PubMed ID: 30851899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.
    Jobsen J; van der Palen J; Riemersma S; Heijmans H; Ong F; Struikmans H
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1006-1014. PubMed ID: 25035203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
    Cutuli B; de Lafontan B; Quetin P; Mery E
    Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.